March 2014 Newsletter

March 19, 2014:

Q4-2013 Decline in Retinal Procedures Likely Due to Extreme Weather Conditions

Survey respondents reported declines in IVT injections, vitrectomies, laser photocoagulation, and Visudyne PDT (photodynamic therapy).

March 19, 2014:

Charity Eases Suffering in Ethiopian Cataract Crisis

Tropical Health Alliance Foundation has a goal of performing 10 thousand cataract surgeries per year by 2020.

March 19, 2014:

FDA Preparing to Make Data Open Source

The agency will allow software developers to tap into its databases to build user-friendly and easily searchable programs for doctors and consumers.

March 19, 2014:

Newer Retinal Surgical Devices Will Fuel Future Revenue Growth

Market Scope anticipates revenue growth of 5 percent for established devices over the next five years, but new technologies should fuel yearly growth of 6.4 percent overall.

March 19, 2014:

House Vote Appears to Doom Current SGR Reform

House Republicans have passed a bill that would pay for SGR reform by delaying penalties associated with the ACA mandate. The measure is expected to die in the Senate.

March 19, 2014:

FDA Panel Recommends US Regulatory Approval of STAAR’s Visian Toric ICL

Panel members’ opinions were mixed, with much of the debate focused on the quality of the data and poor management of the study.

March 19, 2014:

Montagu Private Equity Acquires DORC

Sources close to the sale say that Montagu paid about €200 million, or $270 million.

March 19, 2014:

March 2014 News Briefs

Social media